<
Redcare Pharmacy, NL0012044747

Redcare Pharmacy stock heads into the open after a 4.11 percent drop

Published on 09/10/2026 at 05:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 8, 2026, Redcare Pharmacy stock finished the Xetra session at 56.05 EUR, down 4.11 percent, with around 81,800 shares traded. The move left the stock lagging the SDAX into today’s session.

Automatisiertes Apotheken-Lager mit Robotersystem und unbeschrifteten Medikamentenboxen
Redcare Pharmacy (Shop Apoth), ISIN NL0012044747, zeigt automatisiertes Apotheken-Lager mit Roboter-Regalsystem und markenfreien Medikamentenschachteln, Illustration mit AI erstellt.

Redcare Pharmacy stock closed at 56.05 EUR on Xetra on September 8, 2026, losing 4.11 percent compared with the previous close of 58.45 EUR. The decline left the shares trailing the broader SDAX performance into today’s session.

September 8, 2026 in numbers

Redcare Pharmacy N.V. (ISIN NL0012044747, Xetra: RDC) ended the Frankfurt Xetra session at 56.05 EUR on September 8, 2026, with the closing auction fixed at 17:35 local time according to comdirect Xetra data. The prior session had finished at 58.45 EUR, which explains the daily loss of 4.11 percent on the primary listing. Intraday, the stock traded between a day low of 55.55 EUR and a day high of 58.90 EUR, with approximately 81,821 shares changing hands and a reported cash volume of about 4.63 million euros per session overviews from finanzen100 and comdirect. As Ad-hoc-news.de reported on September 9, 2026, the stock’s decline left it underperforming the SDAX on that day, with the index showing a comparatively milder move than Redcare Pharmacy.

Market cues today

Into today’s session on September 10, 2026, investors in Redcare Pharmacy are primarily facing the continued evaluation of recent share price weakness, with no fresh company-specific releases reported in the morning by major news wires or corporate news portals. As finanzen100 shows in its session overview, the stock currently trades well below its 52-week high of 90.10 EUR, which may keep valuation and sentiment discussions in focus today as the broader SDAX and European equity markets react to recent global risk developments. No specific earnings date within the next days is highlighted for Redcare Pharmacy in the latest publicly accessible earnings calendars, so near-term attention is likely to remain on market-wide factors and sector performance.

Disclaimer...

en | NL0012044747 | REDCARE PHARMACY | boerse | 70078716 | bgmi